| Literature DB >> 29176640 |
Fang Chen1,2, Hao Zhang1,2, Jinjun Li2, Yong Tian2, Jing Xu2, Li Chen2, Jintao Wei1, Na Zhao1, Xuehai Yang1, Wei Zhang1, Lizhi Lu3.
Abstract
Unlike mammals, in palmipedes de novo lipogenesis from diet takes place mostly in the liver. The French Landes Goose is famous for its high capacity and susceptibility to fatty liver production. While miRNAs play a critical role in the posttranscriptional regulation of gene expression, miRNAs that are involved in the regulation of goose hepatic steatosis have yet to be elucidated. Using high-throughput sequencing, we analyzed miRNAs expression profile of Landes goose liver after overfeeding for 21 days. Aan-miR-122-5p was the most frequently sequenced known miRNA, but it was unchanged after overfeeding. Compared with normal liver, we identified that 16 conserved miRNAs were up-regulated while the other 9 conserved miRNAs were down-regulated in fatty livers. Many of their predicted target genes played key roles in metabolic pathways leading to the development of hepatic steatosis in the goose by KEGG pathways analysis. ACSL1 and ELOVL6 were critical genes in hepatic lipid metabolism and had opposite expression patterns with aan-miR-203a and aan-miR-125b-5p, respectively. And we validated that aan-miR-203a and aan-miR-125b-5p might involve in the regulation of hepatic lipid metabolism by targeting ACSL1 and ELOVL6, respectively. These results add to our current understanding of the regulation network in goose lipid metabolism.Entities:
Mesh:
Substances:
Year: 2017 PMID: 29176640 PMCID: PMC5701175 DOI: 10.1038/s41598-017-16632-7
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Effects of overfeeding. (a) Comparison of livers; (b) Comparison of body weight; (c) Comparison of liver mass; (d) Histology observation of normal goose liver (400×); (e) Histology observation of goose liver after overfeeding (400×). **Means P < 0.01.
Figure 2Scatter plot of miRNAs. Each point in the figure represents a miRNA. Red points represent up-regulated miRNAs (fold-change > 2, P < 0.001), green points represent down-regulated miRNAs (fold-change < 0.5, P < 0.001), and blue points represent no significant changed miRNAs (0.5 < fold-change < 2).
Expression predominance of miRNAs in the two groups. The list of miRNAs is arranged in the order of the expression in control group. The order of top 10 miRNAs in overfed group is a little different.
| miR-name | Control | Overfed | Fold-change | ||
|---|---|---|---|---|---|
| Expression | Percent | Expression | Percent | ||
| Aan-miR-122-5p | 593522.14 | 70.34% | 603499.80 | 72.01% | 1.02 |
| Aan-let-7f | 106292.53 | 11.95% | 86157.27 | 9.91% | 0.81 |
| Aan-let-7a | 60272.23 | 6.78% | 53729.91 | 6.18% | 0.89 |
| Aan-miR-140-3p | 8076.96 | 0.91% | 7267.47 | 0.84% | 0.90 |
| Aan-let-7g | 6149.29 | 0.69% | 4683.93 | 0.54% | 0.76 |
| Aan-miR-103/107 | 5457.45 | 0.61% | 6834.39 | 0.79% | 1.25 |
| Aan-let-7b | 4977.79 | 0.56% | 5251.53 | 0.60% | 1.05 |
| Aan-miR-101-3p | 4461.01 | 0.50% | 3620.18 | 0.42% | 0.81 |
| Aan-miR-199 | 4345.30 | 0.49% | 3466.22 | 0.40% | 0.80 |
| Aan-miR-222 | 3016.07 | 0.34% | 8650.00 | 0.99% | 2.87 |
The differentially expressed conserved miRNAs. Differentially expressed miRNAs were identified based on FPKM ≥ 100.00 in either of the two groups, fold change ≥ 1.50 or ≤ 0.67, and P < 0.001. Hsa, Homo sapiens; Gga, Gallus gallus; Tgu, Taeniopygia guttata.
| miR-name | Mature sequences (5′–3′) | Expressed in control | Expressed in overfed | Fold change | Reference |
|---|---|---|---|---|---|
| Aan-miR-1285-3p | CTGGGCAACATAGAGAGACGCG | 321.92 | 0.01 | < 0.01 | hsa |
| Aan-miR-146a-5p | TGAGAACTGAATTCCATGGGTTG | 305.28 | 134.97 | 0.44 | gga |
| Aan-miR-30d-5p | TGTAAACATCCCCGACTGGAAG | 2734.73 | 1348.35 | 0.49 | gga |
| Aan-miR-29a-3p | TAGCACCATTTGAAATCGGTTA | 529.00 | 279.12 | 0.53 | gga |
| Aan-miR-30a-5p | TGTAAACATCCTCGACTGGAAG | 1892.24 | 1070.02 | 0.57 | gga |
| Aan-miR-148a-3p | TCAGTGCACTACAGAACTTTGT | 410.89 | 252.18 | 0.61 | gga |
| Aan-miR-6682a | TGGAACAACGTAGGTAAGGG | 975.09 | 600.20 | 0.62 | gga |
| Aan-miR-125b-5p | TCCCTGAGACCCTAACTTGTGA | 305.57 | 195.03 | 0.64 | gga |
| Aan-miR-100-5p | AACCCGTAGATCCGAACTTGTG | 535.15 | 350.84 | 0.66 | gga |
| Aan-miR-107b | AGCAGCATTGTACAGGGCTTTT | 561.12 | 917.65 | 1.64 | gga |
| Aan-miR-4508 | AGCGGGGCTGGGCGCGCGC | 546.79 | 917.48 | 1.68 | hsa |
| Aan-miR-4492 | CGGGGCTGGGCGCGCGCCGCG | 224.49 | 394.48 | 1.76 | hsa |
| Aan-miR-221-3p | AGCTACATTGTCTGCTGGGTTTC | 4504.39 | 8530.40 | 1.89 | gga |
| Aan-miR-221-5p | ACCTGGCATACAATGTAGATTT | 161.99 | 315.78 | 1.95 | gga |
| Aan-miR-184-3p | TGGACGGAGAACTGATAAGGGT | 651.63 | 1296.59 | 1.99 | gga |
| Aan-miR-193a-5p | TGGGTCTTTGCGGGCGAGATGA | 65.60 | 132.05 | 2.01 | gga |
| Aan-miR-139-3p | TGGAGATGCGGCCCTGTT | 49.05 | 100.25 | 2.04 | gga |
| Aan-miR-148b-3p | TCAGTGCATCACAGAACTTGGT | 609.20 | 1331.80 | 2.19 | hsa |
| Aan-miR-375 | TTTGTTCGTTCGGCTCGCGTTA | 59.06 | 144.42 | 2.44 | gga |
| Aan-miR-222 | AGCTACATCTGGCTACTGGGTC | 6013.67 | 17262.37 | 2.87 | gga |
| Aan-miR-203a | GTGAAATGTTTAGGACCACTTG | 74.16 | 403.57 | 5.44 | gga |
| Aan-miR-2981 | GCTGGGCCGGTCGGGCTGGG | 0.01 | 196.09 | > 50.00 | tgu |
| Aan-miR-3591-5p | TTTAGTGTGACAATGGTGTTTGA | 0.01 | 134.26 | > 50.00 | hsa |
| Aan-miR-3135b | GGCTGGTCCGAGTGCAGTGGTG | 0.01 | 329.73 | > 50.00 | hsa |
| Aan-miR-6682b | TGGAGCATCGTAGGTAAGGG | 0.01 | 616.10 | > 50.00 | gga |
Figure 3Validation of selected miRNAs by qRT-PCR. *Means P < 0.05.
Figure 4The significantly enriched pathways involved in lipid metabolic. KEGG pathway analysis for the predicted target genes of the differentially expressed miRNAs.
Figure 5Regulation networks of the differentially expressed miRNAs and their predicted genes involved in lipid metabolism.
Figure 6Validation of selected target genes. (a) Binding sites for aan-miR-203a in the ACSL1 3′UTR of different species; (b) Binding sites for aan-miR-125b-5p in the ELOVL6 3′UTR of different species; (c) Relative expression of ACSL1 and ELOVL6 in control and overfed liver samples; (d) Luciferase activity assay of the recombined Dual-Luciferase reporter vectors with 3′UTR of ACSL1 or ELOVL6 co-transfected with aan-miR-203a mimic or aan-miR-125b-5p mimic; (e) Relative expression of ACSL1 and ELOVL6 in hepatocytes transfected with aan-miR-203a mimic or aan-miR-125b-5p mimic; (f) The relative content of intracellular lipid in hepatocytes transfected with aan-miR-203a mimic or aan-miR-125b-5p mimic. **Means P < 0.01.